Seshadri Neervannan - Net Worth and Insider Trading
Seshadri Neervannan Net Worth
The estimated net worth of Seshadri Neervannan is at least $3 Million dollars as of 2024-11-09. Seshadri Neervannan is the COO of Tarsus Pharmaceuticals Inc and owns about 64,767 shares of Tarsus Pharmaceuticals Inc (TARS) stock worth over $3 Million. Details can be seen in Seshadri Neervannan's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Seshadri Neervannan has not made any transactions after 2024-03-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Seshadri Neervannan
Seshadri Neervannan Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Seshadri Neervannan owns 1 companies in total, including Tarsus Pharmaceuticals Inc (TARS) .
Click here to see the complete history of Seshadri Neervannan’s form 4 insider trades.
Insider Ownership Summary of Seshadri Neervannan
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TARS | Tarsus Pharmaceuticals Inc | 2024-03-18 | Chief Operating Officer |
Seshadri Neervannan Latest Holdings Summary
Seshadri Neervannan currently owns a total of 1 stock. Seshadri Neervannan owns 64,767 shares of Tarsus Pharmaceuticals Inc (TARS) as of March 18, 2024, with a value of $3 Million.
Latest Holdings of Seshadri Neervannan
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TARS | Tarsus Pharmaceuticals Inc | 2024-03-18 | 64,767 | 49.42 | 3,200,785 |
Holding Weightings of Seshadri Neervannan
Seshadri Neervannan Form 4 Trading Tracker
According to the SEC Form 4 filings, Seshadri Neervannan has made a total of 4 transactions in Tarsus Pharmaceuticals Inc (TARS) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Tarsus Pharmaceuticals Inc is the sale of 4,879 shares on March 18, 2024, which brought Seshadri Neervannan around $149,297.
Insider Trading History of Seshadri Neervannan
- 1
Seshadri Neervannan Trading Performance
Seshadri Neervannan Ownership Network
Ownership Network List of Seshadri Neervannan
Ownership Network Relation of Seshadri Neervannan
Seshadri Neervannan Owned Company Details
What does Tarsus Pharmaceuticals Inc do?
Who are the key executives at Tarsus Pharmaceuticals Inc?
Seshadri Neervannan is the Chief Operating Officer of Tarsus Pharmaceuticals Inc. Other key executives at Tarsus Pharmaceuticals Inc include See Remarks Jeffrey S Farrow , Chief Human Resources Officer Dianne C. Whitfield , and General Counsel Bryan Wahl .
Tarsus Pharmaceuticals Inc (TARS) Insider Trades Summary
Over the past 18 months, Seshadri Neervannan made 1 insider transaction in Tarsus Pharmaceuticals Inc (TARS) with a net sale of 4,879. Other recent insider transactions involving Tarsus Pharmaceuticals Inc (TARS) include a net sale of 240,415 shares made by Bobak R. Azamian , a net sale of 11,909 shares made by Aziz Mottiwala , and a net sale of 12,792 shares made by Bryan Wahl .
In summary, during the past 3 months, insiders sold 35,000 shares of Tarsus Pharmaceuticals Inc (TARS) in total and bought 0 shares, with a net sale of 35,000 shares. During the past 18 months, 331,965 shares of Tarsus Pharmaceuticals Inc (TARS) were sold and 10,506 shares were bought by its insiders, resulting in a net sale of 321,459 shares.
Tarsus Pharmaceuticals Inc (TARS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Tarsus Pharmaceuticals Inc Insider Transactions
Seshadri Neervannan Mailing Address
Above is the net worth, insider trading, and ownership report for Seshadri Neervannan. You might contact Seshadri Neervannan via mailing address: 15440 Laguna Canyon Road, Suite 160, Irvine Ca 92618.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
